These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 861757)

  • 21. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Excitation and inhibition processes in the neurons of the thalamic motor nuclei of normal cats and following an N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced lesion of the nigrostriatal dopaminergic system].
    Voloshin MIa; Lukhanina EP; Kolomiets BP; Burchinskaia LF; Nosenko ND
    Neirofiziologiia; 1989; 21(5):620-9. PubMed ID: 2557553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of striatal drug infusions.
    Tepper JM; Nakamura S; Young SJ; Groves PM
    Brain Res; 1984 Sep; 309(2):317-33. PubMed ID: 6089960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of an afterhyperpolarization by the substantia nigra induces pauses in the tonic firing of striatal cholinergic interneurons.
    Reynolds JN; Hyland BI; Wickens JR
    J Neurosci; 2004 Nov; 24(44):9870-7. PubMed ID: 15525771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accommodation of rat nigrostriatal dopamine neurones to high frequency electrical stimulation of the median forebrain bundle: in vivo voltammetric data.
    Stamford JA; Kruk ZL; Millar J
    Neurosci Lett; 1987 Nov; 82(2):172-6. PubMed ID: 3501081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pallidal control of substantia nigra dopaminergic neuron firing pattern and its relation to extracellular neostriatal dopamine levels.
    Lee CR; Abercrombie ED; Tepper JM
    Neuroscience; 2004; 129(2):481-9. PubMed ID: 15501605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of striatum on the substantia nigra: a study using the spreading depression technique.
    Albe-Fessard D; Sanderson P; Mavoungou R
    Brain Res Bull; 1990 Feb; 24(2):213-9. PubMed ID: 2322855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Origins of postsynaptic potentials evoked in identified rat neostriatal neurons by stimulation in substantia nigra.
    Wilson CJ; Chang HT; Kitai ST
    Exp Brain Res; 1982; 45(1-2):157-67. PubMed ID: 7056322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiological and pharmacological characterization of identified nigrostriatal and mesoaccumbens dopamine neurons in the rat.
    Clark D; Chiodo LA
    Synapse; 1988; 2(5):474-85. PubMed ID: 2903568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions.
    Mango D; Bonito-Oliva A; Ledonne A; Nisticò R; Castelli V; Giorgi M; Sancesario G; Fisone G; Berretta N; Mercuri NB
    Neuropharmacology; 2014 Jan; 76 Pt A():127-36. PubMed ID: 23973317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Synapse; 1990; 5(2):83-93. PubMed ID: 2309160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropharmacological studies on the nigro-striatal and raphe-striatal system in the rat.
    Davies J; Tongroach P
    Eur J Pharmacol; 1978 Sep; 51(2):91-100. PubMed ID: 29766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors.
    Pucak ML; Grace AA
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1181-92. PubMed ID: 7996424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
    Calabresi P; Mercuri NB; Sancesario G; Bernardi G
    Brain; 1993 Apr; 116 ( Pt 2)():433-52. PubMed ID: 8096420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postnatal ontogeny of evoked neuronal responses in the substantia nigra of the cat.
    Fisher RS; Levine MS; Hull CD; Buchwald NA
    Brain Res; 1982 Mar; 255(3):443-62. PubMed ID: 7066699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent inhibition in the rat neostriatum.
    Park MR; Lighthall JW; Kitai ST
    Brain Res; 1980 Aug; 194(2):359-69. PubMed ID: 7388619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane properties and synaptic responses of rat striatal neurones in vitro.
    Jiang ZG; North RA
    J Physiol; 1991 Nov; 443():533-53. PubMed ID: 1822537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postnatal development of the electrical activity of rat nigrostriatal dopaminergic neurons.
    Tepper JM; Trent F; Nakamura S
    Brain Res Dev Brain Res; 1990 Jun; 54(1):21-33. PubMed ID: 2364542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Striatal evoked inhibition of identified nigro-thalamic neurons.
    Deniau JM; Feger J; Le Guyader C
    Brain Res; 1976 Mar; 104(1):152-6. PubMed ID: 1247900
    [No Abstract]   [Full Text] [Related]  

  • 40. Responses of substantia nigra neurones to noxious stimulation.
    Barasi S
    Brain Res; 1979 Jul; 171(1):121-30. PubMed ID: 466432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.